Latest Insider Transactions at Alkermes Plc. (ALKS)
This section provides a real-time view of insider transactions for Alkermes Plc. (ALKS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Alkermes plc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Alkermes plc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 22
2023
|
David Joseph Gaffin EVP, CLO, Alkermes, Inc. |
BUY
Exercise of conversion of derivative security
|
Direct |
7,286
+5.3%
|
-
|
|
Feb 22
2023
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,345
-8.63%
|
$144,315
$27.77 P/Share
|
|
Feb 22
2023
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,038
+16.28%
|
-
|
|
Feb 22
2023
|
Blair Curtis Jackson EVP, Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,088
-2.63%
|
$83,376
$27.77 P/Share
|
|
Feb 22
2023
|
Blair Curtis Jackson EVP, Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,504
+7.5%
|
-
|
|
Feb 21
2023
|
Richard F Pops Director and CEO, Alkermes plc |
SELL
Payment of exercise price or tax liability
|
Direct |
14,386
-1.35%
|
$388,422
$27.77 P/Share
|
|
Feb 21
2023
|
Richard F Pops Director and CEO, Alkermes plc |
BUY
Exercise of conversion of derivative security
|
Direct |
32,400
+2.95%
|
-
|
|
Feb 21
2023
|
David Joseph Gaffin EVP, CLO, Alkermes, Inc. |
SELL
Payment of exercise price or tax liability
|
Direct |
2,022
-1.62%
|
$54,594
$27.77 P/Share
|
|
Feb 21
2023
|
David Joseph Gaffin EVP, CLO, Alkermes, Inc. |
BUY
Exercise of conversion of derivative security
|
Direct |
6,875
+5.22%
|
-
|
|
Feb 21
2023
|
Blair Curtis Jackson EVP, Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,412
-1.29%
|
$38,124
$27.77 P/Share
|
|
Feb 21
2023
|
Blair Curtis Jackson EVP, Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,800
+4.21%
|
-
|
|
Feb 21
2023
|
Michael J Landine SVP, Corp Dev., Alkermes, Inc. |
SELL
Payment of exercise price or tax liability
|
Direct |
2,587
-1.04%
|
$69,849
$27.77 P/Share
|
|
Feb 21
2023
|
Michael J Landine SVP, Corp Dev., Alkermes, Inc. |
BUY
Exercise of conversion of derivative security
|
Direct |
5,825
+2.28%
|
-
|
|
Feb 21
2023
|
Iain Michael Brown SVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,412
-1.78%
|
$38,124
$27.77 P/Share
|
|
Feb 21
2023
|
Iain Michael Brown SVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,800
+5.71%
|
-
|
|
Feb 21
2023
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,053
-5.77%
|
$82,431
$27.77 P/Share
|
|
Feb 21
2023
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,875
+11.5%
|
-
|
|
Feb 20
2023
|
Richard F Pops Director and CEO, Alkermes plc |
SELL
Payment of exercise price or tax liability
|
Direct |
53,145
-4.88%
|
$1,488,060
$28.07 P/Share
|
|
Feb 20
2023
|
Richard F Pops Director and CEO, Alkermes plc |
BUY
Grant, award, or other acquisition
|
Direct |
119,713
+9.91%
|
-
|
|
Feb 20
2023
|
David Joseph Gaffin EVP, CLO, Alkermes, Inc. |
SELL
Payment of exercise price or tax liability
|
Direct |
6,617
-2.8%
|
$185,276
$28.07 P/Share
|
|
Feb 20
2023
|
David Joseph Gaffin EVP, CLO, Alkermes, Inc. |
BUY
Grant, award, or other acquisition
|
Direct |
15,468
+11.21%
|
-
|
|
Feb 20
2023
|
David Joseph Gaffin EVP, CLO, Alkermes, Inc. |
BUY
Exercise of conversion of derivative security
|
Direct |
7,036
+6.06%
|
-
|
|
Feb 20
2023
|
Blair Curtis Jackson EVP, Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,316
-2.07%
|
$120,848
$28.07 P/Share
|
|
Feb 20
2023
|
Blair Curtis Jackson EVP, Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,086
+8.59%
|
-
|
|
Feb 20
2023
|
Blair Curtis Jackson EVP, Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,589
+4.45%
|
-
|
|
Feb 20
2023
|
Michael J Landine SVP, Corp Dev., Alkermes, Inc. |
SELL
Payment of exercise price or tax liability
|
Direct |
7,604
-1.54%
|
$212,912
$28.07 P/Share
|
|
Feb 20
2023
|
Michael J Landine SVP, Corp Dev., Alkermes, Inc. |
BUY
Grant, award, or other acquisition
|
Direct |
11,770
+4.51%
|
-
|
|
Feb 20
2023
|
Michael J Landine SVP, Corp Dev., Alkermes, Inc. |
BUY
Exercise of conversion of derivative security
|
Direct |
5,354
+2.18%
|
-
|
|
Feb 20
2023
|
Christian Todd Nichols SVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,878
-8.56%
|
$220,584
$28.07 P/Share
|
|
Feb 20
2023
|
Christian Todd Nichols SVP, Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,969
+31.06%
|
-
|
|
Feb 20
2023
|
Christian Todd Nichols SVP, Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,824
+11.6%
|
-
|
|
Feb 20
2023
|
Iain Michael Brown SVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,316
-2.9%
|
$120,848
$28.07 P/Share
|
|
Feb 20
2023
|
Iain Michael Brown SVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,086
+11.52%
|
-
|
|
Feb 20
2023
|
Iain Michael Brown SVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,589
+6.26%
|
-
|
|
Feb 20
2023
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,306
-11.74%
|
$288,568
$28.07 P/Share
|
|
Feb 20
2023
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,195
+29.69%
|
-
|
|
Feb 20
2023
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,095
+22.81%
|
-
|
|
Feb 18
2023
|
David Joseph Gaffin EVP, CLO, Alkermes, Inc. |
SELL
Payment of exercise price or tax liability
|
Direct |
1,945
-1.87%
|
$54,460
$28.07 P/Share
|
|
Feb 18
2023
|
David Joseph Gaffin EVP, CLO, Alkermes, Inc. |
BUY
Exercise of conversion of derivative security
|
Direct |
6,230
+5.65%
|
-
|
|
Feb 18
2023
|
Blair Curtis Jackson EVP, Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,683
-2.78%
|
$75,124
$28.07 P/Share
|
|
Feb 18
2023
|
Blair Curtis Jackson EVP, Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,722
+8.28%
|
-
|
|
Feb 18
2023
|
Michael J Landine SVP, Corp Dev., Alkermes, Inc. |
SELL
Payment of exercise price or tax liability
|
Direct |
2,065
-0.87%
|
$57,820
$28.07 P/Share
|
|
Feb 18
2023
|
Michael J Landine SVP, Corp Dev., Alkermes, Inc. |
BUY
Exercise of conversion of derivative security
|
Direct |
4,361
+1.81%
|
-
|
|
Feb 18
2023
|
Christian Todd Nichols SVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,961
-7.19%
|
$54,908
$28.07 P/Share
|
|
Feb 18
2023
|
Christian Todd Nichols SVP, Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,230
+18.6%
|
-
|
|
Feb 18
2023
|
Iain Michael Brown SVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,965
-2.97%
|
$55,020
$28.07 P/Share
|
|
Feb 18
2023
|
Iain Michael Brown SVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,230
+8.61%
|
-
|
|
Feb 18
2023
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,656
-9.94%
|
$74,368
$28.07 P/Share
|
|
Feb 18
2023
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,722
+24.61%
|
-
|
|
Feb 10
2023
|
David Angelo Daglio Jr. Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,445
+22.66%
|
-
|